Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study

Respiration. 2021;100(5):452-460. doi: 10.1159/000514643. Epub 2021 Mar 30.

Abstract

Background: Indwelling pleural catheters (IPC) are increasingly used for management of recurrent (especially malignant) effusions. Pleural infection associated with IPC use remains a concern. Intrapleural therapy with tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) significantly reduces surgical referrals in non-IPC pleural infection, but data on its use in IPC-related pleural infection are scarce.

Objective: To assess the safety and efficacy of intrapleural tPA and DNase in IPC-related pleural infection.

Methods: Patients with IPC-related pleural infection who received intrapleural tPA/DNase in five Australian and UK centers were identified from prospective databases. Outcomes on feasibility of intrapleural tPA/DNase delivery, its efficacy and safety were recorded.

Results: Thirty-nine IPC-related pleural infections (predominantly Staphylococcus aureus and gram-negative organisms) were treated in 38 patients; 87% had malignant effusions. In total, 195 doses (median 6 [IQR = 3-6]/patient) of tPA (2.5 mg-10 mg) and DNase (5 mg) were instilled. Most (94%) doses were delivered via IPCs using local protocols for non-IPC pleural infections. The mean volume of pleural fluid drained during the first 72 h of treatment was 3,073 (SD = 1,685) mL. Most (82%) patients were successfully treated and survived to hospital discharge without surgery; 7 required additional chest tubes or therapeutic aspiration. Three patients required thoracoscopic surgery. Pleurodesis developed post-infection in 23/32 of successfully treated patients. No major morbidity/mortality was associated with tPA/DNase. Four patients received blood transfusions; none had systemic or significant pleural bleeding.

Conclusion: Treatment of IPC-related pleural infection with intrapleural tPA/DNase instillations via the IPC appears feasible and safe, usually without additional drainage procedures or surgery. Pleurodesis post-infection is common.

Keywords: Catheter-related infections; Empyema; Fibrinolytic agents; Pleural diseases; Thoracic surgery; Video-assisted.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Catheters, Indwelling / adverse effects*
  • Deoxyribonucleases / administration & dosage*
  • Deoxyribonucleases / adverse effects
  • Drug Therapy, Combination
  • Empyema, Pleural / microbiology
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Pleural Diseases / drug therapy*
  • Pleural Effusion / microbiology
  • Pleural Effusion / therapy
  • Respiratory Tract Infections / drug therapy
  • Tissue Plasminogen Activator / administration & dosage*
  • Tissue Plasminogen Activator / adverse effects

Substances

  • Fibrinolytic Agents
  • Deoxyribonucleases
  • Tissue Plasminogen Activator